CD Formulation is a biopharmaceutical company focusing on therapeutic proteins/peptides, dedicated to developing and producing biotherapeutics using advanced technology and innovative methods and converting these therapeutic proteins/peptides into oral drugs utilizing innovative drug delivery technologies to enhance the bioavailability and efficacy of the drugs, thereby improving the patient treatment experience.
Our team of experienced scientists and researchers is constantly exploring new ways to improve therapeutic proteins/peptide delivery mechanisms, increase drug stability and targeting, and enhance the overall therapeutic effect of your products. We believe in continuous innovation and research to create cutting-edge solutions for unmet medical needs. We are excited about the possibilities that lie ahead and are confident in helping pharmaceutical companies and research institutions to bring innovative therapies to market.
With extensive experience in therapeutic proteins/peptides and their commercial formulation development, CD Formulation focuses on providing pharmaceutical companies and research institutions with leading biopharmaceutical solutions for proteins/peptides. Whether you want to develop therapeutic protein/peptide or protein/peptide formulations, our team of experts can tailor the best solution for you. Our biopharmaceutical analytical manufacturing services cover the entire process of formulation development, process development, analytical testing, quality control, and cGMP commercial manufacturing.